Halozyme Therapeutics shares owned by Verition Fund Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Verition Fund Management
from 13F filings
Historical chart of Verition Fund Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Verition Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.0M | 68k | 73.34 |
| 2025-06-30 | $1.7M | 34k | 52.02 |
| 2025-03-31 | $1.5M | 24k | 63.81 |
| 2024-12-31 | $1.9M | 39k | 47.81 |
| 2024-09-30 | $211k | 3.7k | 57.24 |
| 2024-06-30 | $243k | 4.6k | 52.36 |
| 2024-03-31 | $254k | 6.2k | 40.68 |
| 2023-09-30 | $395k | 10k | 38.20 |
| 2023-06-30 | $339k | 9.4k | 36.07 |
| 2023-03-31 | $441k | 12k | 38.19 |
| 2022-06-30 | $655k | 15k | 44.03 |
| 2021-12-31 | $4.3M | 107k | 40.21 |
| 2021-06-30 | $1.6M | 36k | 45.42 |
| 2021-03-31 | $370k | 8.9k | 41.64 |
| 2020-09-30 | $392k | 15k | 26.25 |
| 2020-03-31 | $264k | 17k | 15.63 |
| 2019-12-31 | $1.6M | 88k | 17.73 |
| 2019-09-30 | $1.2M | 76k | 15.55 |
| 2019-06-30 | $880k | 51k | 17.17 |
| 2018-09-30 | $182k | 10k | 18.12 |
| 2017-06-30 | $263k | 21k | 12.83 |
| 2017-03-31 | $177k | 14k | 12.98 |
| 2014-06-30 | $160k | 16k | 9.88 |